Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility

Neurology

Volumn 56, Issue 8, 2001, Pages 1015-1020

  Barber, P A ^a   Zhang, J ^a   Demchuk, A M ^a   Hill, M D ^a   Buchan, A M ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b FOOTHILLS HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE;

AGED; ARTICLE; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; COMORBIDITY; DRUG INDICATION; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT TRANSPORT; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE; SUBDURAL HEMATOMA; SYMPTOMATOLOGY;

EID: 0035942340     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.56.8.1015     Document Type: Article

References (27)

1. Tissue plasminogen activator for acute ischemic stroke
2. Predicted impact of intravenous thrombolysis on prognosis of general population of stroke patients: Simulation model
3. A systematic audit of intravenous tPA in Cleveland Area hospitals
4. Treatment and secondary prevention of stroke: Evidence, costs, and effects on individuals and populations
5. Effects of public and professional education on reducing the delay in presentation and referral of stroke patients
6. Building a brain attack team for thrombolytic therapy in acute ischemic stroke
7. Experience from a multicentre stroke register: A preliminary report
8. Classification and natural history of clinically identifiable subtypes of cerebral infarction
9. Reliability and validity of estimating NIH stroke scale from medical records
10. Effectiveness of t-PA in acute ischemic stroke: Outcome relates to appropriateness
11. Thrombolytic therapy versus control in acute ischemic stroke
12. Intra-arterial thrombolysis in acute basilar artery thromboembolism: The initial Mayo Clinic experience
13. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: A randomised controlled trial
14. Stroke thrombolysis: Is tissue plasminogen activator a defribrillator for the brain?
15. Cincinnati prehospital stroke scale: Reproducibility and validity
16. Identifying stroke in the field: Prospective validation of the Los Angeles Prehospital Stroke Screen (LAPSS)
17. "Telestroke": The application of telemedicine for stroke
18. Acute stroke treatment in UK hospitals: The Stroke Association survey of consultant opinion
19. Validity and reliability of a quantitative computed tomography score in predicting outcome in hyperacute stroke before thrombolytic therapy
20. Intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 80 years and older: The tPA stroke survey experience
21. Limitations of clinical diagnosis in acute stroke
22. Vascular imaging predicts early clinical fluctuation in patients with acutely resolving symptoms of cerebral ischemia
23. Patients' awareness of stroke signs, symptoms, and risk factors
24. Treatment of acuteischemic stroke: Challenging the concept of a rigid and universal time window
25. Use of tissue-type plasminogen activator for acute ischemic stroke. The Cleveland experience
26. Intravenous tissue plasminogen activator for treatment of acute stroke. The Standard Treatment with Alteplase to Reverse Stroke (STARS) study